Plenary

ISSCR 2018 Plenary and Concurrent

4 - STRATEGIES TO IMPROVE THE EFFICACY OF CAR T CELLS IN HEMATOLOGIC MALIGNANCIES AND SOLID TUMORS

6/23/2018
16:35 - 17:00

Stanley R. Riddell

University of Washington, WA, United States

Dr. Stanley Riddell is a Member in the Program in Immunology and Director of the Integrated Immunotherapy Research Center at the Fred Hutchinson Cancer Research Center. His research focuses on understanding T cell immunity to pathogens and tumors, and on the development and clinical application of adoptive T cell therapy for cancer using genetic modification of T cells to confer tumor specificity and overcome barriers to tumor eradication.

Presentation(s):

Send Email for Stanley Riddell

Send Email for Shivani Srivastava

Send Email for Alex Salter

Send Email for Margot Pont

Send Email for Josh Veatch

Send Email for Isabel Leung

Send Email for Simon Fraessle


Assets

4 - STRATEGIES TO IMPROVE THE EFFICACY OF CAR T CELLS IN HEMATOLOGIC MALIGNANCIES AND SOLID TUMORS



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for STRATEGIES TO IMPROVE THE EFFICACY OF CAR T CELLS IN HEMATOLOGIC MALIGNANCIES AND SOLID TUMORS